OMEROS CORP Financing Cash Flow
OMEROS CORP (OMER) reported Financing Cash Flow of -$29.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
- OMEROS CORP net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$7.47M.
- OMEROS CORP net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$21.98M.
- OMEROS CORP net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$64.44M.
- OMEROS CORP net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $25.82M.
- OMEROS CORP net cash provided by (used in) financing activities for fiscal 2025 was -$42.17M, a 167.06% decline from fiscal 2024.
- OMEROS CORP net cash provided by (used in) financing activities for fiscal 2024 was $62.88M.
- OMEROS CORP net cash provided by (used in) financing activities for fiscal 2023 was -$106.08M, a 185.38% decline from fiscal 2022.
- OMEROS CORP net cash provided by (used in) financing activities for fiscal 2022 was $124.25M, a 1866.26% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 204 month | Net Cash Provided by (Used in) Financing Activities 207 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$29.45M 10-Q · filed 2026-08-12 | -$93.89M derived: sum of 3 quarters · filed 2026-08-12 | -$68.06M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | -$21.98M 10-Q · filed 2026-05-13 | -$86.42M derived: sum of 2 quarters · filed 2026-05-13 | -$60.60M derived: sum of 3 quarters · filed 2026-05-13 | -$62.31M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | -$64.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$38.61M derived: sum of 2 quarters · filed 2026-03-31 | -$40.33M derived: sum of 3 quarters · filed 2026-08-12 | -$42.17M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $25.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $24.11M derived: sum of 2 quarters · filed 2026-08-12 | $22.27M 10-Q · filed 2025-11-13 | $18.18M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.56M 10-Q · filed 2026-08-12 | -$7.65M derived: sum of 3 quarters · filed 2026-08-12 | -$12.23M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$1.84M 10-Q · filed 2026-05-13 | -$5.93M derived: sum of 2 quarters · filed 2026-05-13 | -$10.51M derived: sum of 3 quarters · filed 2026-05-13 | -$37.39M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$8.67M derived: sum of 2 quarters · filed 2026-03-31 | -$35.55M derived: sum of 3 quarters · filed 2026-03-31 | $62.88M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$31.45M derived: sum of 2 quarters · filed 2025-11-13 | $66.98M 10-Q · filed 2025-11-13 | -$37.98M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-06-30 | -$26.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $71.56M 10-Q · filed 2025-08-14 | -$33.40M derived: sum of 3 quarters · filed 2026-03-31 | -$33.88M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-03-31 | $98.43M 10-Q · filed 2025-05-15 | -$6.52M derived: sum of 2 quarters · filed 2026-03-31 | -$7.00M derived: sum of 3 quarters · filed 2026-03-31 | -$7.26M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2023-12-31 | -$104.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$105.44M derived: sum of 2 quarters · filed 2026-03-31 | -$105.70M derived: sum of 3 quarters · filed 2026-03-31 | -$106.08M 10-K · filed 2026-03-31 | ||
| 2023-09-30 | -$483.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$743.00K derived: sum of 2 quarters · filed 2024-11-13 | -$1.13M 10-Q · filed 2024-11-13 | -$1.78M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-06-30 | -$260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$648.00K 10-Q · filed 2024-08-07 | -$1.30M derived: sum of 3 quarters · filed 2025-03-31 | $123.54M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-03-31 | -$388.00K 10-Q · filed 2024-05-15 | -$1.04M derived: sum of 2 quarters · filed 2025-03-31 | $123.80M derived: sum of 3 quarters · filed 2025-03-31 | $123.70M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2022-12-31 | -$651.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $124.19M derived: sum of 2 quarters · filed 2025-03-31 | $124.09M derived: sum of 3 quarters · filed 2025-03-31 | $124.25M 10-K · filed 2025-03-31 | ||
| 2022-09-30 | $124.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $124.74M derived: sum of 2 quarters · filed 2023-11-09 | $124.90M 10-Q · filed 2023-11-09 | $124.09M derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2022-06-30 | -$99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $62.00K 10-Q · filed 2023-08-09 | -$748.00K derived: sum of 3 quarters · filed 2024-04-01 | -$270.00K derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2022-03-31 | $161.00K 10-Q · filed 2023-05-09 | -$649.00K derived: sum of 2 quarters · filed 2024-04-01 | -$171.00K derived: sum of 3 quarters · filed 2024-04-01 | $684.00K derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2021-12-31 | -$810.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$332.00K derived: sum of 2 quarters · filed 2024-04-01 | $523.00K derived: sum of 3 quarters · filed 2024-04-01 | $6.32M 10-K · filed 2024-04-01 | ||
| 2021-09-30 | $478.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.33M derived: sum of 2 quarters · filed 2022-11-09 | $7.13M 10-Q · filed 2022-11-09 | $6.97M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2021-06-30 | $855.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $6.65M 10-Q · filed 2022-08-09 | $6.49M derived: sum of 3 quarters · filed 2023-03-13 | $178.94M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2021-03-31 | $5.80M 10-Q · filed 2022-05-10 | $5.63M derived: sum of 2 quarters · filed 2023-03-13 | $178.08M derived: sum of 3 quarters · filed 2023-03-13 | $177.93M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2020-12-31 | -$163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $172.29M derived: sum of 2 quarters · filed 2023-03-13 | $172.13M derived: sum of 3 quarters · filed 2023-03-13 | $174.53M 10-K · filed 2023-03-13 | ||
| 2020-09-30 | $172.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $172.30M derived: sum of 2 quarters · filed 2021-11-09 | $174.70M 10-Q · filed 2021-11-09 | $231.17M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $2.25M 10-Q · filed 2021-08-09 | $58.72M derived: sum of 3 quarters · filed 2022-03-01 | $61.78M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $2.40M 10-Q · filed 2021-05-10 | $58.88M derived: sum of 2 quarters · filed 2022-03-01 | $61.93M derived: sum of 3 quarters · filed 2022-03-01 | $63.24M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $56.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $59.53M derived: sum of 2 quarters · filed 2022-03-01 | $60.84M derived: sum of 3 quarters · filed 2022-03-01 | $60.70M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.37M derived: sum of 2 quarters · filed 2020-11-09 | $4.22M 10-Q · filed 2020-11-09 | $34.31M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.16M 10-Q · filed 2020-08-10 | $31.25M derived: sum of 3 quarters · filed 2021-03-01 | $34.97M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | -$146.00K 10-Q · filed 2020-05-11 | $29.95M derived: sum of 2 quarters · filed 2021-03-01 | $33.66M derived: sum of 3 quarters · filed 2021-03-01 | $80.36M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $30.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $33.81M derived: sum of 2 quarters · filed 2021-03-01 | $80.51M derived: sum of 3 quarters · filed 2021-03-01 | $81.05M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $3.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $50.42M derived: sum of 2 quarters · filed 2019-11-12 | $50.96M 10-Q · filed 2019-11-12 | $52.07M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $46.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $47.25M 10-Q · filed 2019-08-08 | $48.35M derived: sum of 3 quarters · filed 2020-03-02 | $116.73M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $544.00K 10-Q · filed 2019-05-09 | $1.65M derived: sum of 2 quarters · filed 2020-03-02 | $70.03M derived: sum of 3 quarters · filed 2020-03-02 | $74.44M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $69.48M derived: sum of 2 quarters · filed 2020-03-02 | $73.90M derived: sum of 3 quarters · filed 2020-03-02 | $75.00M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $68.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $72.79M derived: sum of 2 quarters · filed 2018-11-08 | $73.89M 10-Q · filed 2018-11-08 | $82.69M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $5.51M 10-Q · filed 2018-08-09 | $14.31M derived: sum of 3 quarters · filed 2019-03-01 | $51.78M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $1.10M 10-Q · filed 2018-05-10 | $9.90M derived: sum of 2 quarters · filed 2019-03-01 | $47.36M derived: sum of 3 quarters · filed 2019-03-01 | $68.19M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $46.27M derived: sum of 2 quarters · filed 2019-03-01 | $67.09M derived: sum of 3 quarters · filed 2019-03-01 | $68.70M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $37.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $58.29M derived: sum of 2 quarters · filed 2017-11-09 | $59.90M 10-Q · filed 2017-11-09 | $69.81M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $20.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $22.43M 10-Q · filed 2017-08-08 | $32.35M derived: sum of 3 quarters · filed 2018-03-01 | $30.56M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $1.61M 10-Q · filed 2017-05-10 | $11.53M derived: sum of 2 quarters · filed 2018-03-01 | $9.74M derived: sum of 3 quarters · filed 2018-03-01 | $7.78M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $9.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $8.13M derived: sum of 2 quarters · filed 2018-03-01 | $6.17M derived: sum of 3 quarters · filed 2018-03-01 | $86.83M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | -$1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$3.74M derived: sum of 2 quarters · filed 2016-11-09 | $76.91M 10-Q · filed 2016-11-09 | $77.72M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | -$1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $78.69M 10-Q · filed 2016-08-09 | $79.51M derived: sum of 3 quarters · filed 2017-03-16 | $79.78M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | $80.65M 10-Q · filed 2016-05-10 | $81.47M derived: sum of 2 quarters · filed 2017-03-16 | $81.74M derived: sum of 3 quarters · filed 2017-03-16 | $82.28M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | $813.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.08M derived: sum of 2 quarters · filed 2017-03-16 | $1.62M derived: sum of 3 quarters · filed 2017-03-16 | $50.86M 10-K · filed 2017-03-16 | ||
| 2014-09-30 | $272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $811.00K derived: sum of 2 quarters · filed 2015-11-09 | $50.04M 10-Q · filed 2015-11-09 | $55.51M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $539.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $49.77M 10-Q · filed 2015-08-10 | $55.24M derived: sum of 3 quarters · filed 2016-03-15 | $55.26M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $49.23M 10-Q · filed 2015-05-11 | $54.70M derived: sum of 2 quarters · filed 2016-03-15 | $54.72M derived: sum of 3 quarters · filed 2016-03-15 | $70.86M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2013-12-31 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $5.49M derived: sum of 2 quarters · filed 2016-03-15 | $21.63M derived: sum of 3 quarters · filed 2016-03-15 | $21.65M 10-K · filed 2016-03-15 | ||
| 2013-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $16.16M derived: sum of 2 quarters · filed 2014-11-10 | $16.18M 10-Q · filed 2014-11-10 | $21.10M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $16.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $16.16M 10-Q · filed 2014-08-11 | $21.07M derived: sum of 3 quarters · filed 2015-03-16 | $51.93M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $22.00K 10-Q · filed 2014-05-12 | $4.93M derived: sum of 2 quarters · filed 2015-03-16 | $35.79M derived: sum of 3 quarters · filed 2015-03-16 | $34.37M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $35.76M derived: sum of 2 quarters · filed 2015-03-16 | $34.35M derived: sum of 3 quarters · filed 2015-03-16 | $32.97M 10-K · filed 2015-03-16 | ||
| 2012-09-30 | $30.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $29.44M derived: sum of 2 quarters · filed 2013-11-07 | $28.06M 10-Q · filed 2013-11-07 | $27.18M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-06-30 | -$1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$2.79M 10-Q · filed 2013-08-09 | -$3.67M derived: sum of 3 quarters · filed 2014-03-13 | -$3.58M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-03-31 | -$1.38M 10-Q · filed 2013-05-09 | -$2.26M derived: sum of 2 quarters · filed 2014-03-13 | -$2.16M derived: sum of 3 quarters · filed 2014-03-13 | -$2.09M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2011-12-31 | -$881.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$788.00K derived: sum of 2 quarters · filed 2014-03-13 | -$714.00K derived: sum of 3 quarters · filed 2014-03-13 | $9.49M 10-K · filed 2014-03-13 | ||
| 2011-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $167.00K derived: sum of 2 quarters · filed 2012-11-09 | $10.37M 10-Q · filed 2012-11-09 | $11.27M derived: sum of 4 quarters · filed 2013-03-18 | $158.50M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $10.27M 10-Q · filed 2012-08-07 | $11.18M derived: sum of 3 quarters · filed 2013-03-18 | $9.86M derived: sum of 4 quarters · filed 2013-03-18 | $158.40M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $10.20M 10-Q · filed 2012-05-10 | $11.11M derived: sum of 2 quarters · filed 2013-03-18 | $9.79M derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $907.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$413.00K derived: sum of 2 quarters · filed 2013-03-18 | -$2.96M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$3.87M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | -$2.55M 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $59.52M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |